Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years

Thyroid

Volumn 16, Issue 11, 2006, Pages 1151-1155

  Trimboli, P ^a   Ulisse, S ^a   Graziano, F M ^a   Marzullo, A ^a   Ruggieri, M ^a   Calvanese, A ^a   Piccirilli, F ^a   Cavaliere, R ^a   Fumarola, A ^a   D'Armiento, Massimino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANAPLASTIC CARCINOMA; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER REGISTRY; CANCER SIZE; CELL DIFFERENTIATION; EVALUATION; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; TREND STUDY;

AGE DISTRIBUTION; CARCINOMA; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; HUMANS; ITALY; MORTALITY; REGISTRIES; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; THYROID NEOPLASMS;

EID: 33845241503     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.1151     Document Type: Article

References (28)

1. Sherman SI 2003 Thyroid carcinoma. Lancet 36:501-511.
2. Kinder BK 2003 Well differentiated thyroid cancer. Curr Opin Oncol 15:71-77.
3. Pasieka JL 2003 Anaplastic thyroid cancer. Curr Opin Oncol 15:78-83.
4. Sarlis NJ 2000 Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects. Rev Endocr Metab Dis 1:183-196.
5. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogen in human thyroid carcinoma. Science 289:1357-1360.
6. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn II GW, Tallini G, Kroll TG, Nikiforov YE 2003 Ras point mutations and PAX8-PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326.
7. Fagin JA 2002 Perspective: lesson learned from molecular genetic studies of thyroid cancer-insights into pathogenesis and tumor-specific therapeutic targets. Endocrinology 143:2025-2028.
8. Shahedian B, Shi Y, Zou M, Farid NR 2001 Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab 72:155-163.
9. Sobin LH, Wittekind C 2002 TNM classification of malignant tumors, 6th ed. UICC. Wiley-Liss, New York, pp 52-56.
10. Passler C, Scheuba C, Asari R, Kaczirek K, Kaserer K, Niederle 2005 Importance of tumor size in papillary and follicular thyroid cancer. Br J Surg 92:184-189.
11. Besic N, Zgajnar J, Hocevar M, Frkovic-Grazio S 2005 Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 5:439-448.
12. Casella C, Fusco M 2004 Thyroid cancer. Epidemiol Prev 28:88-91.
13. Aghini-Lombardi F, Antonangeli L, Vitti P, Pinchera A 1993 Status of iodine nutrition in Italy. In: Delange F, Dunn JT, Glinoer D (eds) Iodine Deficiency in Europe. A Continuing Concern. Plenum Press, New York, pp 403-408.
14. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911.
15. Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating FR Jr 1961 Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg 102:354-387.
16. Selwyn T 1979 Clinical features of thyroid tumors. Clin Endocrinol Metab 8:209-221.
17. Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma. Cancer 79:564-573.
18. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ 2000 Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control 11:163-170.
19. Ron E, Modan B (1982) Thyroid. In: Schottenfeld D, Fraumeni JF (eds) Cancer Epidemiology and Prevention. WB Saunders, Philadelphia, pp 837-854.
20. Farahati J, Geling M, Mader U, Mortl M, Luster M, Muller JG, Flentje M, Reiners C 2004 Changing trends of incidence and prognosis of thyroid carcinomas in lower Franconia, Germany, from 1981-1995. Thyroid 14:141-147.
21. Lundgren CI, Hall P, Ekbom A, Frisell J, Zenedius J, Dickman PW 2003 Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 106:569-573.
22. Kuijpens JL, Hansen B, Hamming JF, Ribot JG, Haak HR, Coebergh JWW 1998 Trends in treatment and long-term survival of thyroid cancer in Southeastern Netherlands, 1960-1992. Eur J Cancer 34:1235-1241.
23. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
24. Burgess JR, Tucker P 2006 Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16:47-53.
25. Livolsi VA, Asa SL 1994 The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233-236.
26. Mazzaferri EL 2001 Histologic variants of papillary thyroid carcinoma. Endocr Prac 7:139-142.
27. Mazzaferri EL 2006 Managing small thyroid cancers. JAMA 295:2179-2182.
28. Cooper BS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-141.